Stockholder alert: the m&a class action firm announces the investigation of leap therapeutics, inc. - lptx

New york , jan. 18, 2023 /prnewswire/ -- juan monteverde , founder and managing partner of the class action firm monteverde & associates pc (the "m&a class action firm"), a national securities firm rated top 50 in the 2018-2021 iss securities class action services report and headquartered at the empire state building in new york city, is investigating leap therapeutics, inc. (nasdaq: lptx), relating to its proposed purchase of flame biosciences, inc. under the terms of the agreement, lptx will issue shares of common stock and series x non-voting convertible preferred stock to flame shareholders, with each series x share convert to 1000 shares of common stock upon approval of the transaction. click here for more information: https://www.monteverdelaw.com/case/leap-therapeutics-inc.
LPTX Ratings Summary
LPTX Quant Ranking